01. Bayanin Nunin
A ranar 8 ga Oktoba, 2024 CPHI Pharmaceutical Exhibition ya fara a Milan. A matsayin daya daga cikin muhimman abubuwan da suka faru na shekara-shekara a masana'antar harhada magunguna ta duniya, ya jawo mahalarta daga kasashe da yankuna 166. Tare da masu baje koli sama da 2,400 da ƙwararrun masu halarta 62,000, nunin ya rufe murabba'in murabba'in 160,000. A yayin taron, an gudanar da taruka da taruka sama da 100, inda suka tattauna batutuwa daban-daban da suka hada da ka'idojin harhada magunguna da sabbin fasahohin magunguna zuwa magungunan biopharmaceutical da ci gaba mai dorewa.
02. JYMed's Highlights
Shenzhen JYMed Technology Co., Ltd. (wanda ake kira "JYMed"), a matsayin daya daga cikin manyan masana'antun peptide a kasar Sin, ya gabatar da sababbin fasahohi, samfurori, da damar haɗin gwiwar abokan ciniki a duniya a nunin Milan. A yayin taron, ƙungiyar JYMed ta tsunduma cikin tattaunawa mai zurfi tare da kamfanonin harhada magunguna da abokan ciniki daga ko'ina cikin duniya, tare da musayar ra'ayoyi kan muhimman batutuwa a cikin masana'antar peptide tare da ba da shawarwari masu mahimmanci da shawarwari don ci gaban masana'antu a nan gaba.
JYMed yana alfahari da dandamali na kasa da kasa don bincike da samar da peptides, abubuwan da ake kira peptide-like, da peptide-drug conjugates (PDCs). Kamfanin yana da ƙwarewa a cikin hadadden peptide kira, core peptide chemistry, da manyan-sikelin samar fasahar. Ta kafa haɗin gwiwar dabarun dogon lokaci tare da shahararrun kamfanoni na duniya. JYMed ya yi imanin cewa ta hanyar raba albarkatu da ƙarin ƙarfi, zai iya kawo ƙarin bege da zaɓuɓɓuka ga marasa lafiya a duk duniya.
03. Takaitacciyar Baje kolin
Jagoran falsafar "Peptides don kyakkyawar makoma," JYMed za ta ci gaba da tuki da sabbin hanyoyin samar da magunguna da ba da gudummawa ga lafiya da jin daɗin marasa lafiya a duniya. Muna fatan yin aiki tare da takwarorinsu na duniya don rungumar kyakkyawar makoma ga masana'antar harhada magunguna.
Game da JYMed
Shenzhen JYMed Technology Co., Ltd. (nan gaba ake magana a kai a matsayin JYMed) an kafa a 2009, ƙware a cikin bincike, ci gaba, samarwa, da kuma tallace-tallace na peptides da peptide alaka kayayyakin. Tare da cibiyar bincike guda ɗaya da manyan sansanonin samarwa guda uku, JYMed yana ɗaya daga cikin manyan masu samar da peptide API ɗin da aka haɗa ta sinadarai a cikin Sin. Babban ƙungiyar R&D na kamfanin yana alfahari sama da shekaru 20 na gogewa a cikin masana'antar peptide kuma ta sami nasarar wuce binciken FDA sau biyu. JYMed ta m da ingantaccen tsarin masana'antu peptide masana'antu yayi abokan ciniki cikakken kewayon ayyuka, ciki har da ci gaba da kuma samar da warkewa peptides, dabbobi peptides, antimicrobial peptides, da kwaskwarima peptides, kazalika da rajista da kuma kayyade goyon baya.
Babban Ayyukan Kasuwanci
1. Rijistar gida da na duniya na peptide APIs
2. peptides na dabbobi da na kwaskwarima
3. peptides na al'ada da CRO, CMO, sabis na OEM
4. Magungunan PDC (peptide-radionuclide, peptide-kananan kwayoyin halitta, peptide-protein, peptide-RNA)
Baya ga Tirzepatide, JYMed ya ƙaddamar da takaddun rajista tare da FDA da CDE don wasu samfuran API da yawa, gami da shahararrun magungunan ajin GLP-1RA a halin yanzu kamar Semaglutide da Liraglutide. Abokan ciniki na gaba masu amfani da samfuran JYMed za su iya yin la'akari kai tsaye lambar rajistar CDE ko lambar fayil ɗin DMF lokacin ƙaddamar da aikace-aikacen rajista ga FDA ko CDE. Wannan zai rage mahimmancin lokacin da ake buƙata don shirya takaddun aikace-aikacen, da kuma lokacin kimantawa da farashin bitar samfur.
Tuntube Mu
Shenzhen JYMed Technology Co., Ltd.
Adireshi:8th & 9th Floors, Gine 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Waya:+ 86 755-26612112
Yanar Gizo: http://www.jymedtech.com/
Lokacin aikawa: Oktoba-18-2024